发明名称 Transgenic flies expressing Abeta42-Arctic
摘要 The present invention discloses a transgenic fly that expresses the Arctic mutant version of the human Abeta42 peptide of human amyloid-beta precursor protein (APP), and a double transgenic fly that expresses both the Tau protein and the human Abeta42<SUB>Arctic </SUB>peptide of human amyloid-beta precursor protein (APP). The transgenic flies of the present invention provide for models of neurodegenerative disorders, such as Alzheimer's disease. The invention further discloses methods for identifying genetic modifiers, as well as screening methods to identify therapeutic compounds to treat neurodegenerative disorders using the transgenic flies.
申请公布号 US2005132421(A1) 申请公布日期 2005.06.16
申请号 US20040969893 申请日期 2004.10.21
申请人 ENVIVO PHARMACEUTICALS, INC. 发明人 LOWE DAVID A.;KOENIG GERHARD;CUMMINGS CHRISTOPHER J.
分类号 A01K67/00;A01K67/033;C12N15/85;G01N33/00;(IPC1-7):A01K67/033 主分类号 A01K67/00
代理机构 代理人
主权项
地址